Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.96.00 CHF
Change Today 0.00 / 0.00%
Volume 3.5K
HBMN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Berlin
OTC US
As of 11:43 AM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

hbm bioventures ag-a (HBMN) Snapshot

Open
SFr.96.00
Previous Close
SFr.96.00
Day High
SFr.96.30
Day Low
SFr.95.75
52 Week High
05/27/15 - SFr.107.64
52 Week Low
10/16/14 - SFr.76.34
Market Cap
768.0M
Average Volume 10 Days
9.6K
EPS TTM
--
Shares Outstanding
8.0M
EX-Date
07/1/15
P/E TM
--
Dividend
SFr.5.50
Dividend Yield
5.73%
Current Stock Chart for HBM BIOVENTURES AG-A (HBMN)

Related News

No related news articles were found.

hbm bioventures ag-a (HBMN) Related Businessweek News

No Related Businessweek News Found

hbm bioventures ag-a (HBMN) Details

HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts. The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries. It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage. The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe. In case of public companies, it focuses on those which originate from its private portfolio. The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company’s IPO. It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company’s Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives. The fund exits its portfolio companies through trade sale or IPO.

Founded in 2001

hbm bioventures ag-a (HBMN) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: --
Chief Financial Officer
Total Annual Compensation: --
Secretary to the Board of Directors
Total Annual Compensation: --
Advisor
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

hbm bioventures ag-a (HBMN) Key Developments

HBM Healthcare Investments AG Reports Earnings Results for the First Quarter Ended June 30, 2015

HBM Healthcare Investments reported earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported the company posted a loss of CHF 45.5 million overall for the quarter. Approximately half of this was attributable to foreign currency movements.

HBM Healthcare Investments AG to Report Fiscal Year 2015 Results on Jun 02, 2015

HBM Healthcare Investments AG announced that they will report fiscal year 2015 results on Jun 02, 2015

HBM Healthcare Investments AG to Report Q2, 2015 Results on Jul 31, 2015

HBM Healthcare Investments AG announced that they will report Q2, 2015 results on Jul 31, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HBMN:SW SFr.96.00 CHF 0.00

HBMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HBMN.
View Industry Companies
 

Industry Analysis

HBMN

Industry Average

Valuation HBMN Industry Range
No financial data is available for HBMN.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HBM BIOVENTURES AG-A, please visit www.hbmhealthcare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.